Connect with us


IM Cannabis Provides Business, Legal and Regulatory Update – New Cannabis Ventures



  • IMC subsidiary Adjupharm is expanding its German product portfolio with unique varieties through supply agreements with The Green Organic Dutchman and Natural MedCo
  • German Brand Institute honors IMC with the “German Brand Award 2021” for the company’s successful market launch campaign
  • The Israeli Ministerial Committee on Legislative Affairs approved a bill on July 11 to legalize CBD and decriminalize cannabis users

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 13, 2021 / IM Cannabis Corp. (“IMC” or the “Company”) (CSE: IMCC) (NASDAQ: IMCC), a multi-country operator (“MCO”) in the field of medical and recreational cannabis for adults with offices in Israel, Germany and Canada, is pleased to provide a business, legal and regulatory update on its activities in Germany and Israel.

Update on operation in Germany

The company’s EU GMP certified German subsidiary, Adjupharm GmbH (“Adjupharm”), has signed two new medical cannabis supply agreements that expand its product portfolio and provide a better basis for the distribution of medical cannabis in the EU .

Details of the two new Adjupharm supply contracts are as follows:

  • The Green Organic Dutchman Holdings Ltd. (“TGOD”): During the first two-year term of this supply agreement (the “TGOD Agreement”), Adjupharm will add the organic strains of TGOD to the Adjupharm portfolio and order at least 300 kg in the first year and at least 400 kg in the second year, subject to appropriate regulatory approvals . As part of the TGOD agreement, TGOD will supply medical cannabis for an Adjupharm-exclusive variety that is due to be launched in Germany this year.
  • Natural MedCo Ltd. (“NMC”): During the first three year term of this Agreement (the “NMC Agreement” and, together with the TGOD Agreement, the “Supply Agreements”), Adjupharm will order up to 660 kg of EU GMP) -certified medicinal cannabis strains from NMC. These strains will be new offers on the German market. Adjupharm has an option under the NMC agreement to increase the amount of medicinal cannabis and include additional strains. Adjupharm assumes that the NMC products delivered under the NMC agreement will be launched in Germany in the second half of 2021.

Adjupharm has binding distribution agreements with sales partners reaching over 6,000 pharmacies to support its growing product portfolio for the German market and as one of the few German distributors with a curated product portfolio of premium, high-THC, high-CBD and balanced varieties of some of which are exclusive. All strains meet strict pharmaceutical standards for import into Germany.

As a company that has a strong focus on its patients and their wellbeing, it is important that we continue to improve our product portfolio by building key strategic relationships with proven leaders in the cannabis industry.

Oren Shuster, CEO, IMC

With Adjupharm signed new supply agreements with TGOD and Natural MedCo, we are well positioned to meet the unique health needs of our German patients by sourcing high quality, consistent medicinal cannabis strains for the treatment of specific diseases.

“We continue to select our delivery partners carefully and carefully, based on our industry expertise and in-depth knowledge of the German market,” adds Richard Balla, CEO, Adjupharm. “We strive to provide our German doctors with the best available medicinal cannabis strains in the world to ensure they can give their patients a superior quality of life.”

German Brand Award 2021

IMC is pleased to announce that the German Brand Institute has awarded IMC’s brand launch campaign the “German Brand Award 2021”, one of the most influential marketing prizes in Germany. The award recognizes the outstanding achievements of IMC in the areas of brand strategy and creation, communication and integrated marketing.

Update on operations in Israel

  • Regulatory update: On July 11, a bill to legalize CBD and decriminalize cannabis users received the approval of the Committee of Ministers on Legislative Matters and is expected to be subject to a preliminary reading in the Israeli parliament later this week. The carve-out of CBD from Israel’s Dangerous Drugs Regulation paves the way for consumption as a consumer product in multiple product categories such as dietary supplements, cosmetics, and oils. This bill also represents a practical move towards legalizing cannabis, a goal the new coalition government committed to during its campaign.[1]
  • Update planning and building law procedures: As disclosed in the company’s annual information form dated April 26, 2021, Focus Medical Herbs Ltd. (“Focus Medical”), a company over which the company “de facto” exercises control, advised the presiding community committee on planning and construction in southern Israel (the “Construction Committee”) in December 2020 that it was the subject of certain allegations of inadequate building permits in terms of its cultivation facilities. On July 11, IMC was first informed that the Construction Committee had initiated legal proceedings against Focus Medical, Oren Shuster and certain other Focus Medical shareholders and stakeholders (the “Construction Proceedings”). Due to the construction process, the company does not currently expect any material effects on the licensing or normal course operation of Focus Medical. The company, Focus Medical and Mr. Shuster cooperate in every respect in the construction process. The company will continue to provide information on major developments.

About IM Cannabis Corp.

IMC is an MCO in the field of medicinal and recreational cannabis for adults with headquarters in Israel and offices in Israel, Germany and Canada. Over the past decade, the company believes that the IMC brand has become synonymous with quality and durability in the Israeli medical cannabis market. The company has also expanded its business to provide intellectual property-related services to the medical cannabis industry.

In Europe, IMC operates through Adjupharm, a Germany-based subsidiary and an EU GMP certified distributor for medical cannabis. IMC’s European presence is complemented by strategic alliances with various pan-European EU GMP breeders and traders in order to benefit from the increased demand for medical cannabis products in Europe and to make the IMC brand and its product portfolio accessible to European patients.

In Canada, IMC is through Trichome JWC Acquisition Corp. d / b / a JWC active. JWC is a licensed producer based in Kitchener, Ontario, selling cannabis flower, pre-rolls, hashish and kief to the Canadian recreational cannabis market under the JWC and WAGNERS brands. JWC works to high standards in providing clean, consistent, premium aeroponically grown cannabis products to medical patients and the adult market across Canada and the world. IMC also operates MYM Nutraceuticals Inc. (“MYM”) and its licensed manufacturing subsidiary, Highland Grow Inc.

About The Green Organic Dutchman Holdings Ltd.

TGOD is a premium certified, organically grown cannabis company focused on the health and wellness market. His organic cannabis is grown in living soil as nature intended. TGOD is committed to a better future by producing its products responsibly, with less waste and less environmental impact. Its Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flowers and oil and has recently launched a range of next generation cannabis products such as hashish, vapes, organic teas and soluble powders. TGOD also sells premium hemp CBD oil and CBD-infused topicals in Europe through its European subsidiary HemPoland. Using science and technology, TGOD harnesses the power of nature from seed to sale.

The common stock and warrants of TGOD issued pursuant to the Notes dated December 19, 2019, June 12, 2020, October 23, 2020 and December 10, 2020 will be traded on the TSX under the symbol “TGOD”, “TGOD.WS” , “TGOD. WR “,” TGOD.WA “or” TGOD.WB “and TGODF are traded on the OTCQX in the USA. More information about The Green Organic Dutchman Holdings Ltd. can be found at

About Natural MedCo Ltd.

NMC holds cultivation and processing licenses under the Cannabis Act (Canada) for the manufacture and sale of various cannabis products, including dried cannabis, cannabis plants and the extraction of cannabis oil, and has received EU GMP certification. NMC was Canada’s first licensed female medical marijuana producer and received its cultivation license from Health Canada in 2016. NMC is led by a team of agricultural professionals and has a licensed 1,000,000 square foot greenhouse in Strathroy, Ontario, Canada.

NMC is a wholly owned subsidiary of Eve & Co Inc (“Eve”). Eve trades on the TSX-V under the symbol EVE and on the OTCQX in the United States under the symbol EEVVF. For more information about Eve, please visit the company’s website at


Original press release

Published by NCV Newswire

NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to curate quality content and information on leading cannabis companies to help our readers filter out the noise and stay up to date on the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated anyway. Do you have a confidential news tip? Get in touch.

Get our Sunday newsletter

In this article:

Adjupharm, eevff, Eve, Eve und Co, Germany, Green Organic Dutchman, im Cannabis, imc, imcc, Natural MedCo, TGOD, TGODF

Similar news:

The interstate cannabis trade is an exaggerated concern for now

IM Cannabis Completes Acquisition of Premium Cannabis Producer

Global cannabis stocks are down 8.7% in the second quarter

Canadian cannabis stocks rose 1% in June

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Dollar-starved Sri Lanka Seeks Relief Through Cannabis Export



Dollar-hungry Sri Lanka is on the verge of dismantling a deadlock to allow the commercial cultivation of cannabis. With immediate effect, the cultivation of the weed is prohibited except in indigenous medicine, and that too under strict state control.

But cannabis cultivation and export could be profitable given the burgeoning global market for the weed.

Cannabis exports could bring in millions, if not billions of dollars, which can be used to mitigate Sri Lanka’s overwhelming foreign debt to some extent. The global cannabis market is expected to grow as the UN Narcotics Commission (UNCND) reclassifies cannabis as a “therapeutic product”.

According to the Central Bank of Sri Lanka, Sri Lanka’s external debt rose from $ 47 billion in the first quarter of 2021 to $ 50 billion in the second quarter of 2021. Currency reserves have now dropped to $ 2.3 billion.

On November 30th, Lankan Indigenous Medicine Minister Sisira Jayakody informed parliament that the government had decided to enact a law within three months that would prohibit the cultivation of cannabis for both the local production of medicines and for the Export allowed.

“High quality medicinal cannabis can be used to treat cancer, neurological diseases, mental disorders, as a pain reliever, and also in the beauty culture industry. It can be used in treating COVID. But it was forbidden when we were under British rule, ”said Jayakody.

Earlier, at a meeting in a rural area, President Gotabaya Rajapaksa announced that he would advocate the cultivation of cannabis for medicinal purposes as it is part of traditional Sri Lankan medicine. On October 7th, 2020, Prime Minister Mahinda Rajapaksa announced to parliament: “Our government is considering applications to legalize cannabis.”

The challenge

However, the change in cannabis policy could encounter inclement weather. As of now, the cannabis trade in Sri Lanka is illegal. The government will take possession and sale of the substance with fines and imprisonment.

The Poison, Opium and Dangerous Drugs Act states: “No one may sow, plant, cultivate, maintain or possess or collect poppy, coca or hemp plants or the seeds, pods, leaves, flowers or plants without the permission of the Minister have any part of such a plant in their possession. “

The law further states: “No person may (a) collect, prepare, process, sell or offer for sale, manufacture, store, receive or have in his possession, distribute resins obtained from the hemp plant for the preparations or extracts or use from the hemp plant commonly known as bhang, hashish or ganja, or any other preparation from which this resin is separated. “

Despite calls for legalization of cannabis cultivation in the country (as many Western nations lifted the ban), Sri Lankan religious leaders protested violently. In 2020, ven. Dhammalankara Thera (Chief Prelate of Kotte Sri Kalayani Samagri Dharma Maha Sangha of Siyam Maha Nikaya) said the lifting of the ban would create a “national problem”.

The medical profession also seems to be against it. According to the Sri Lankan National Council of Mental Health (NCMH), cannabis “abuse” can have severe psychological and sociological consequences. “Cannabis use is associated with apathy, sedation and disinhibition. cognitive dysfunction and poor self-care. Cannabis use can also increase the risk of psychotic disorders and lead to a poor prognosis for those with a proven susceptibility to psychosis. The prevalence of cannabis use is higher among people with psychosis in our country, ”says the NCMH.

However, the NCMH recognizes the medicinal benefits of cannabis-based preparations. This is because these are made according to strict Ayurvedic principles.

Burgeoning world market

Be that as it may, the dollar’s lure is stronger than other considerations, especially when Sri Lanka is financially in dire straits.

Indian trade specialist Suhyl Abidi, who writes for the website of the Trade Promotion Council of India, says the world market for cannabidiol (CBD), a chemical found in cannabis, will grow by 21.8% in value, from $ 5.49 billion Dollars (in 2019) to $ 26.25 billion by 2027.

“This is being driven primarily by the increased use of CBD in medical applications, supplements, beverages, and skin care. CBD products have been advertised for a variety of health problems such as anxiety, insomnia, drug addiction, and acne, ”says Abidi.

He points out that there is a stigma attached to the use of hemp cannabis, as it is confused with marijuana, as both belong to the cannabis family. Cannabis contains two psychoactive compounds, tetrahydrocannabinol (THC) and cannabidiol (CBD). The high levels of THC in marijuana are responsible for getting it “high”. Legal hemp has to contain 0.3% THC or less, which is not enough to get you high, he points out.

CBD is a therapeutically important derivative of cannabis and is sold in the form of gels, gums, oils, nutritional supplements and extracts. Abidi says that hemp seeds are a “superfood” that can boost immunity.

According to Abidi, the cannabidiol market is likely to see significant R&D investment in the pharmaceutical industry around the world. The first cannabidiol drug, Epidiolex, was approved by the US FDA, confirming some of the therapeutic benefits of cannabidiol.

Madness in the USA

In 2019, CBD became one of the top 40 best-selling ingredients in mainstream US retail stores for the first time. CBD sales were $ 36 million, making it the ninth largest nutritional supplement ingredient sold. Sales of CBD rose a remarkable 872.3% from 2018 to 2019 – the largest increase among the top 40 mainstream ingredients. Abidi points this out.

It is estimated that 64 million US adults have tried CBD in the past two years. Among respondents, the most common reason they took CBD was to relax and relieve stress / anxiety. 64% rated CBD as “extremely or very effective”.

Abidi cited “World’s Top Exports” to say that exports of cannabis oils from all countries totaled $ 2.9 billion in 2019. That was an increase of 23.3% for all cannabis oil exporters from 2015. India was the second largest exporter with 320.8 million US dollars (11.1% share) of sales, after China, which in 2019 was 964 million US dollars (33rd , 4% share) exported.

The export growth of some smaller countries was many times higher. For example: Vietnam (plus 529.5%), Madagascar (plus 232.2%), Morocco (plus 218.1%) and the Netherlands (plus 124.5%).

Abidi says governments should provide the right direction, policies, and regulatory framework for the medical cannabis industry to thrive. The excessive regulatory stranglehold on the opium industry has steadily reduced the number of licensed growers, which has significantly reduced exports, he emphasizes. Using India as an example, he says: “In 2016 India exported 98 tons. But in 2018 it was 48 tons, in 2019 it was 14 tons according to ITC Trade Map data. “

Cannabis and its derivatives are banned in India under the Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985. However, India voted in the UN Narcotics Commission (UNCND) in December 2020 to decriminalize cannabis. Hence, measures to decriminalize it in India can follow.

Last year, Pakistan allowed cannabis to be grown as an export crop, as the country is also short of dollars.

In Bangladesh, all narcotics, including marijuana, were made illegal by the Narcotics Control Act of 1990. Under the law, the cultivation, production, processing, transportation, transportation, importing, exporting, supplying, buying, selling, owning, preserving, storing, displaying, or using any type of narcotic drug, including marijuana, is illegal. However, the law allows the manufacture, processing, import, export, supply, purchase and sale of narcotic drugs for any licensed medicinal product or for the conduct of any scientific research, provided that this is done under license.

However, it is very unlikely that Bangladesh will allow the cultivation of cannabis as a commercial crop, as Prime Minister Sheikh Hasina has opposed drugs, no matter how mild and harmless they may be. Your government had gone on a rampage to ruthlessly exterminate drug dealers.

Continue Reading


Cannagenix CBD Gummies Review: Legit CBD Square Gummies?



In today’s rapidly changing routines, it has become increasingly difficult to breathe calmly, relax, and loosen up. With challenging roles and busy schedules, many people around the world live busy and hectic lifestyles. You are therefore at an increased risk of numerous diseases as a result of a deteriorated general state of health.

Keeping mental health in check is very important. A person’s ability to deal with a wide variety of situations and circumstances depends mainly on their mental and physical health. A CBD supplement can help relieve stress and anxiety, no matter how severe they are.

Because of its stress-, anxiety-relieving, and anti-inflammatory properties, this natural compound is an excellent remedy for those who are overly stressed out. CBD gummies make it easy to get your daily dose of CBD, and they taste great too. To deal with these issues like pain, anxiety, and stress, you can use CBD to nourish the body and calm the mind.

Cannagenix CBD Gummies, a newly launched CBD edible, promises to alleviate joint pain and related health problems. CBD edibles have become one of the most popular and widely used CBD nutritional supplements available today for the relief of pain, insomnia, stress, and anxiety. You get a dose of high quality, complete isolate in each gummy bear that improves almost every aspect of your body’s endocannabinoid system. Professional athletes and bodybuilders can also benefit from this natural treatment.

How do Cannagenix CBD gummies compare to their promises of calming and healing? Is it safe to take? Why is it so effective? This review of Cannagenix CBD Gummies will address all of those concerns.

Let’s start with the Cannagenix CBD test!

What are Cannagenix CBD gums?

It is safe and natural to use Cannagenix CBD gummies to combat stress and anxiety issues. Cannagenix CBD contains a filtered hemp extract that does not contain THC substances (which cause a high) to maximize cannabis’ healing potential, according to the official website. Cannagenix uses only the highest quality, fully isolated hemp oil that is commercially available at any time. The cannabidiol in Cannagenix full-spectrum CBD gums is enough to treat various ailments, including chronic sleep problems, anxiety, stress, joint pain, and more.

Cannagenix CBD gums contain a proprietary blend of pain relieving ingredients that cannot be found anywhere else. Thanks to these gummy bears, the digestive system is protected from irregular acid circulation. This speeds up digestion and absorption of the nutrients in the food. These gummy bears are widely used for acne and other skin problems. Because they affect skin cells instantly, these CBD gums are ideal for treating various skin problems.

There are no psychedelic effects as all components are safe and free from harmful substances. You can rest assured that Cannagenix CBD gummies are made in an FDA approved facility that complies with GMP guidelines.

The science behind Cannagenix CBD gums

Relaxation, eating, sleeping, pain, and cognitive functions are all controlled by your endocannabinoid system (ECS). ECS ensures that body functions run smoothly. A very well-functioning ECS ​​is essential for a pain-free and healthy body. Problems such as stress and anxiety, insomnia, chronic pain and high blood pressure can be alleviated with Cannagenix, which is extracted from the hemp plant, and can help the body regulate the ECS system.

Cannabidiol, the active ingredient in Cannagenix, is quickly absorbed and distributed throughout the body, resulting in an anti-inflammatory and tension-reducing effect. The Cannagenix CBD Gummies are made from raw, unfiltered and unheated hemp oil, which offers all of the benefits of the hemp plant without using dangerous chemicals and causing no harm.

ALSO READ:Keoni CBD Gummies Review (Legit or Scam) Crucial Update

Cannabinoids help the endocannabinoid system perform its functions when the body cannot produce enough endocannabinoids. Taking CBD can help you focus, be more conscious, and remember memorable moments faster. People who suffer from chronic migraines and headaches can also benefit from CBD. Put simply, Cannagenix CBD is a must-have item on your stock list.

What components does Cannegenix contain?

The components of Cannagenix CBD are formulated with all-natural ingredients. There have been various research studies and tests that have proven the quality and effectiveness of CBD. Cannagenix CBD gummies use CBD as the main ingredient from hemp. Fully isolated cannabidiol is incorporated into the formulation. By reducing stress, anxiety, and nervousness, this can have positive effects on mental health. By helping the body absorb minerals and nutrients, they are effective in nourishing the body. No degree of sensitivity to its specific elements is known.

Guidelines for the buyer:

Using Cannagenix CBD gums is a quick and easy way to alleviate a wide variety of ailments. According to the Cannagenix official website, consuming at least one gummy bear a day has a significant and positive impact on your overall health and quality of life. Likewise, the square gum from Cannagenix CBD is easy to consume. It is recommended that you wait at least six hours before taking another dose of CBD gums as the rate of absorption is more constant than that of CBD oil.

ALSO READ:Shark Tank CBD Gummies: Buyer Attention Guide to Avoiding Scams

To guarantee its safety and effectiveness, CBD hemp extract is used in a unique formula. Ingesting some CBD gums can help you relax and feel better. If you are sensitive to cannabis, you may experience nausea, vomiting, or vomiting with Cannagenix CBD gummies. Using a CBD product with a prescription drug should be discussed with your health professional first so that it does not cause any adverse reactions.

Where to Buy Cannagenix CBD Gums?:

You can buy Cannagenix CBD gums from the official website for $ 6.97, which is the shipping cost of the product. Customers should also be aware that by purchasing the CBD gums they are also agreeing to a monthly auto-shipping program. If customers do not wish to participate in the auto-ship program, they can call the company or cancel via email.

The Cannagenix CBD gummies come with a 100% money back guarantee. Within 48 hours of receiving the returned CBD gummies, the Cannagenix customer service team will issue a refund to your credit card account minus the return shipping costs.

The Cannagenix User Support team is available to answer your questions in the following ways:

  • Customer Service Toll Free: 1-866-842-1966
  • Return address: 14100 McCormick Dr. Tampa, FL 33626 USA
  • Email:


These Cannagenix CBD gums are safe and effective. They are best for people who can’t stop thinking about their stress and pain issues and want a break from constant worries. As a result, health problems become easier to deal with for the user. In addition, these CBD-infused gums strengthen the body’s resilience and help fight inflammation. Your body and mind will be rejuvenated and you will feel younger. In addition, it can help relieve pain and relieve anxiety in the body.

Many people benefit from and continue to benefit from Cannagenix CBD gummies. By taking the CBD gums daily, those stressed out from everyday life can enjoy their lives more and worry less.

Get Cannagenix CBD Gummies Today!

TIED TOGETHER:Eagle Hemp CBD Gummies Review: Don’t Buy Until You See This

Affiliate Disclosure:

The links included in this product review may result in a small commission if you choose to purchase the recommended product at no additional cost to you. This is to support our research and editorial team and please note that we only recommend high quality products.


Please understand that the advice or guidelines listed here are not even remotely a substitute for in-depth medical advice from a licensed healthcare provider. Make sure to consult a professional health care professional before making a purchase decision if you are taking any medication or have any concerns about following the verification details above. The individual results may differ as the statements about these products have not been evaluated by the Food and Drug Administration. The effectiveness of these products has not been confirmed by FDA approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Continue Reading


BlosumCBD Launches New Auto-ship Program with 25% Discount and Other Perks



NEWPORT BEACH, CALIFORNIA., December 1, 2021 / PRNewswire / – BlosumCBD and its CBD products have everything a customer could want. In their online shop you can choose between THC-free and full-spectrum formulations as well as other cannabidiol products.

Have you ever had trouble remembering to take your daily CBD supplements? It’s easier than ever with BlosumCBD’s auto-ship program. This membership is for those who want to access CBD products with no problem or worry. Just set up your subscription and let Blosum do the rest!

BlosumCBD, a California-based CBD company, has several CBD products for every need and has just launched its new auto-ship program. The benefits of Blosum’s new automatic shipping program include a 25% discount on all your orders, the ability to cancel or pause at any time, and change future orders.

It’s easy to sign up for the CBD Auto Shipping Program and start saving money today. Simply select the “Subscribe & Save” button on any of the products you want to buy. Then select the frequency of how often you would like to receive the broadcast.

BlosumCBD, a California-based CBD company has multiple CBD products for every need and has just launched its new auto-ship program. The benefits of Blosum’s new automatic shipping program include a 25% discount on all your orders, the ability to cancel or pause at any time, and change future orders.

Best of all, you save 25% off the retail price on every order as long as you stay a member of the Blosum Auto Shipping program, which can include free shipping! This is different from other brands that only offer 10-15%. You can also cancel your subscription to BlosumCBD at any time.

BlosumCBD strives to provide our customers with high quality CBD products that are easy and convenient to use. In addition, they offer an exclusive auto-shipping program that can help with those busy schedules.

It’s easy to sign up for the Auto-Ship program and start saving money today. Simply select the “Subscribe & Save” button on any of the products you want to buy. Then select the frequency of how often you would like to receive the broadcast.

This can be every month to every two months, whatever the user’s preference. Then your order will be delivered to your door automatically. BlosumCBD membership is easy and can be canceled at any time. Simply log into your account and cancel your membership at least 72 hours before renewal.

The BlosumCBD Auto-Ship Program is a great way to help you find the best CBD product for your needs. Unfortunately, it takes a few tries to find the right CBD product for you and BlosumCBD knows that.

You can change your subscription orders as you learn more about how your body reacts to different CBD products to help you find the best form of CBD and potency for optimal health benefits.

Users who recommend BlosumCBD to a friend will receive a $ 30 Credit if your friend buys their first BlosumCBD product. If you have a subscription, your credit will then be applied to your next broadcast and deducted from your monthly total.

E-mail: [email protected] to redeem yours $ 30 Credit.

Remember this auto-shipping program because the auto-shipping program will not allow you to use any other coupon codes, promotions, discounts, or limited-time offers. Subscriptions are not available for bundled products that have already been discounted, and subscription orders must remain active for five consecutive orders in order to qualify for the free fifth product.

To learn more about BlosumCBD’s auto-ship program, visit

About Blosum:
BlosumCBD is an organic hemp oil company based in Newport Beach, California. The main role of BlosumCBD is to improve the health and wellbeing of future generations and they use organic hemp plants that are grown in California. For more information on BlosumCBD’s products, please visit

Media contact:
Shane Anthony
[email protected]


Continue Reading